Epilepsy surgery, antiepileptic drug trials, and the role of evidence
Summary Objective: We assessed whether recent randomized controlled trials (RCTs) of antiepileptic drugs (AEDs) are informed by evidence about surgical effectiveness. We explored whether RCTs of AEDs consider the patients’ candidacy for surgery in their eligibility criteria, and whether the necessa...
Gespeichert in:
| Veröffentlicht in: | Epilepsia (Copenhagen) 2010-06, Vol.51 (6), p.1004-1009 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1009 |
|---|---|
| container_issue | 6 |
| container_start_page | 1004 |
| container_title | Epilepsia (Copenhagen) |
| container_volume | 51 |
| creator | Janszky, Jozsef Kovacs, Norbert Gyimesi, Csilla Fogarasi, Andras Doczi, Tamás Wiebe, Samuel |
| description | Summary
Objective: We assessed whether recent randomized controlled trials (RCTs) of antiepileptic drugs (AEDs) are informed by evidence about surgical effectiveness. We explored whether RCTs of AEDs consider the patients’ candidacy for surgery in their eligibility criteria, and whether the necessary investigations are requested in participating patients to determine their potential eligibility for surgery.
Methods: We systematically analyzed RCTs published in the last 2 years investigating the efficacy of new AEDs in localization‐related epilepsy. Results from a surgical RCT and recommendations from an epilepsy surgery practice parameter were used to assess the degree to which surgical evidence informed the drug study design.
Results: Eleven RCTs were analyzed. All were conducted in countries with access to epilepsy surgery. None of the studies required magnetic resonance imaging (MRI) with an epilepsy protocol or explicit statement of the epilepsy syndrome, which could lead to the identification of surgical candidates. Having temporal lobe epilepsy or being a potential surgical candidate were not exclusion criteria in any of the trials. The primary efficacy end point was the reduction in seizure frequency or responder rate. Seizure freedom was never the primary outcome, and it was reported in only seven studies. The pooled data analysis of these trials revealed that 1.9% of patients became seizure‐free on placebo and 4.4% on the study drug (p |
| doi_str_mv | 10.1111/j.1528-1167.2010.02566.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746230618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733962594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4806-db5a5929e99f92328d001ebbf5d5bf96bd1934dca9c7b5a35c2def7be612d7d03</originalsourceid><addsrcrecordid>eNqNkD1PwzAQhi0EglL4C8gLYiHFH7ETDwyoKh9SJRhgthz7AqnSptgJtP8epy0wghdbd8-dXz0IYUpGNJ6r2YgKlieUymzESKwSJqQcrfbQ4KexjwaEUJ4okZMjdBzCjBCSyYwfoiNGeJ5mVA7QZLKsaliGNQ6dfwW_vsRm0VawqbaVxc53r7j1lalD33K4fQPsmxpwU2L4qBwsLJyggzICcLq7h-jldvI8vk-mj3cP45tpYtOcyMQVwgjFFChVKsZZ7mJCKIpSOFGUShaOKp46a5TNIsqFZQ7KrABJmcsc4UN0sd279M17B6HV8ypYqGuzgKYLOksl40TS_G-ScyWZUGkk8y1pfROCh1IvfTU3fq0p0b1tPdO9VN1L1b1tvbGtV3H0bPdJV8zB_Qx-643A-Q4wwZq69GZhq_DLsWgh5X3a6y33GbWv_x1AT54e-hf_AkoCmlY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733962594</pqid></control><display><type>article</type><title>Epilepsy surgery, antiepileptic drug trials, and the role of evidence</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Janszky, Jozsef ; Kovacs, Norbert ; Gyimesi, Csilla ; Fogarasi, Andras ; Doczi, Tamás ; Wiebe, Samuel</creator><creatorcontrib>Janszky, Jozsef ; Kovacs, Norbert ; Gyimesi, Csilla ; Fogarasi, Andras ; Doczi, Tamás ; Wiebe, Samuel</creatorcontrib><description>Summary
Objective: We assessed whether recent randomized controlled trials (RCTs) of antiepileptic drugs (AEDs) are informed by evidence about surgical effectiveness. We explored whether RCTs of AEDs consider the patients’ candidacy for surgery in their eligibility criteria, and whether the necessary investigations are requested in participating patients to determine their potential eligibility for surgery.
Methods: We systematically analyzed RCTs published in the last 2 years investigating the efficacy of new AEDs in localization‐related epilepsy. Results from a surgical RCT and recommendations from an epilepsy surgery practice parameter were used to assess the degree to which surgical evidence informed the drug study design.
Results: Eleven RCTs were analyzed. All were conducted in countries with access to epilepsy surgery. None of the studies required magnetic resonance imaging (MRI) with an epilepsy protocol or explicit statement of the epilepsy syndrome, which could lead to the identification of surgical candidates. Having temporal lobe epilepsy or being a potential surgical candidate were not exclusion criteria in any of the trials. The primary efficacy end point was the reduction in seizure frequency or responder rate. Seizure freedom was never the primary outcome, and it was reported in only seven studies. The pooled data analysis of these trials revealed that 1.9% of patients became seizure‐free on placebo and 4.4% on the study drug (p < 0.01).
Conclusions: Important aspects of patient selection for new AED trials are not informed by the evidence about surgical effectiveness. Investigations that could lead to identification of patients for presurgical evaluation were not required in any of the studies.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>DOI: 10.1111/j.1528-1167.2010.02566.x</identifier><identifier>PMID: 20384716</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Anticonvulsants - therapeutic use ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Epilepsy - drug therapy ; Epilepsy - epidemiology ; Epilepsy - surgery ; Epilepsy treatment ; Evidence-Based Medicine - methods ; Evidence‐based medicine ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Magnetic resonance imaging ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropharmacology ; Pharmacology. Drug treatments ; Randomized Controlled Trial ; Randomized Controlled Trials as Topic - methods ; Temporal lobe epilepsy surgery</subject><ispartof>Epilepsia (Copenhagen), 2010-06, Vol.51 (6), p.1004-1009</ispartof><rights>Wiley Periodicals, Inc. © 2010 International League Against Epilepsy</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4806-db5a5929e99f92328d001ebbf5d5bf96bd1934dca9c7b5a35c2def7be612d7d03</citedby><cites>FETCH-LOGICAL-c4806-db5a5929e99f92328d001ebbf5d5bf96bd1934dca9c7b5a35c2def7be612d7d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1528-1167.2010.02566.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1528-1167.2010.02566.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22923438$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20384716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Janszky, Jozsef</creatorcontrib><creatorcontrib>Kovacs, Norbert</creatorcontrib><creatorcontrib>Gyimesi, Csilla</creatorcontrib><creatorcontrib>Fogarasi, Andras</creatorcontrib><creatorcontrib>Doczi, Tamás</creatorcontrib><creatorcontrib>Wiebe, Samuel</creatorcontrib><title>Epilepsy surgery, antiepileptic drug trials, and the role of evidence</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Summary
Objective: We assessed whether recent randomized controlled trials (RCTs) of antiepileptic drugs (AEDs) are informed by evidence about surgical effectiveness. We explored whether RCTs of AEDs consider the patients’ candidacy for surgery in their eligibility criteria, and whether the necessary investigations are requested in participating patients to determine their potential eligibility for surgery.
Methods: We systematically analyzed RCTs published in the last 2 years investigating the efficacy of new AEDs in localization‐related epilepsy. Results from a surgical RCT and recommendations from an epilepsy surgery practice parameter were used to assess the degree to which surgical evidence informed the drug study design.
Results: Eleven RCTs were analyzed. All were conducted in countries with access to epilepsy surgery. None of the studies required magnetic resonance imaging (MRI) with an epilepsy protocol or explicit statement of the epilepsy syndrome, which could lead to the identification of surgical candidates. Having temporal lobe epilepsy or being a potential surgical candidate were not exclusion criteria in any of the trials. The primary efficacy end point was the reduction in seizure frequency or responder rate. Seizure freedom was never the primary outcome, and it was reported in only seven studies. The pooled data analysis of these trials revealed that 1.9% of patients became seizure‐free on placebo and 4.4% on the study drug (p < 0.01).
Conclusions: Important aspects of patient selection for new AED trials are not informed by the evidence about surgical effectiveness. Investigations that could lead to identification of patients for presurgical evaluation were not required in any of the studies.</description><subject>Anticonvulsants - therapeutic use</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Epilepsy - drug therapy</subject><subject>Epilepsy - epidemiology</subject><subject>Epilepsy - surgery</subject><subject>Epilepsy treatment</subject><subject>Evidence-Based Medicine - methods</subject><subject>Evidence‐based medicine</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Magnetic resonance imaging</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Randomized Controlled Trial</subject><subject>Randomized Controlled Trials as Topic - methods</subject><subject>Temporal lobe epilepsy surgery</subject><issn>0013-9580</issn><issn>1528-1167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1PwzAQhi0EglL4C8gLYiHFH7ETDwyoKh9SJRhgthz7AqnSptgJtP8epy0wghdbd8-dXz0IYUpGNJ6r2YgKlieUymzESKwSJqQcrfbQ4KexjwaEUJ4okZMjdBzCjBCSyYwfoiNGeJ5mVA7QZLKsaliGNQ6dfwW_vsRm0VawqbaVxc53r7j1lalD33K4fQPsmxpwU2L4qBwsLJyggzICcLq7h-jldvI8vk-mj3cP45tpYtOcyMQVwgjFFChVKsZZ7mJCKIpSOFGUShaOKp46a5TNIsqFZQ7KrABJmcsc4UN0sd279M17B6HV8ypYqGuzgKYLOksl40TS_G-ScyWZUGkk8y1pfROCh1IvfTU3fq0p0b1tPdO9VN1L1b1tvbGtV3H0bPdJV8zB_Qx-643A-Q4wwZq69GZhq_DLsWgh5X3a6y33GbWv_x1AT54e-hf_AkoCmlY</recordid><startdate>201006</startdate><enddate>201006</enddate><creator>Janszky, Jozsef</creator><creator>Kovacs, Norbert</creator><creator>Gyimesi, Csilla</creator><creator>Fogarasi, Andras</creator><creator>Doczi, Tamás</creator><creator>Wiebe, Samuel</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>201006</creationdate><title>Epilepsy surgery, antiepileptic drug trials, and the role of evidence</title><author>Janszky, Jozsef ; Kovacs, Norbert ; Gyimesi, Csilla ; Fogarasi, Andras ; Doczi, Tamás ; Wiebe, Samuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4806-db5a5929e99f92328d001ebbf5d5bf96bd1934dca9c7b5a35c2def7be612d7d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anticonvulsants - therapeutic use</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Epilepsy - drug therapy</topic><topic>Epilepsy - epidemiology</topic><topic>Epilepsy - surgery</topic><topic>Epilepsy treatment</topic><topic>Evidence-Based Medicine - methods</topic><topic>Evidence‐based medicine</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Magnetic resonance imaging</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Randomized Controlled Trial</topic><topic>Randomized Controlled Trials as Topic - methods</topic><topic>Temporal lobe epilepsy surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janszky, Jozsef</creatorcontrib><creatorcontrib>Kovacs, Norbert</creatorcontrib><creatorcontrib>Gyimesi, Csilla</creatorcontrib><creatorcontrib>Fogarasi, Andras</creatorcontrib><creatorcontrib>Doczi, Tamás</creatorcontrib><creatorcontrib>Wiebe, Samuel</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janszky, Jozsef</au><au>Kovacs, Norbert</au><au>Gyimesi, Csilla</au><au>Fogarasi, Andras</au><au>Doczi, Tamás</au><au>Wiebe, Samuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epilepsy surgery, antiepileptic drug trials, and the role of evidence</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2010-06</date><risdate>2010</risdate><volume>51</volume><issue>6</issue><spage>1004</spage><epage>1009</epage><pages>1004-1009</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><coden>EPILAK</coden><abstract>Summary
Objective: We assessed whether recent randomized controlled trials (RCTs) of antiepileptic drugs (AEDs) are informed by evidence about surgical effectiveness. We explored whether RCTs of AEDs consider the patients’ candidacy for surgery in their eligibility criteria, and whether the necessary investigations are requested in participating patients to determine their potential eligibility for surgery.
Methods: We systematically analyzed RCTs published in the last 2 years investigating the efficacy of new AEDs in localization‐related epilepsy. Results from a surgical RCT and recommendations from an epilepsy surgery practice parameter were used to assess the degree to which surgical evidence informed the drug study design.
Results: Eleven RCTs were analyzed. All were conducted in countries with access to epilepsy surgery. None of the studies required magnetic resonance imaging (MRI) with an epilepsy protocol or explicit statement of the epilepsy syndrome, which could lead to the identification of surgical candidates. Having temporal lobe epilepsy or being a potential surgical candidate were not exclusion criteria in any of the trials. The primary efficacy end point was the reduction in seizure frequency or responder rate. Seizure freedom was never the primary outcome, and it was reported in only seven studies. The pooled data analysis of these trials revealed that 1.9% of patients became seizure‐free on placebo and 4.4% on the study drug (p < 0.01).
Conclusions: Important aspects of patient selection for new AED trials are not informed by the evidence about surgical effectiveness. Investigations that could lead to identification of patients for presurgical evaluation were not required in any of the studies.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20384716</pmid><doi>10.1111/j.1528-1167.2010.02566.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0013-9580 |
| ispartof | Epilepsia (Copenhagen), 2010-06, Vol.51 (6), p.1004-1009 |
| issn | 0013-9580 1528-1167 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_746230618 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection |
| subjects | Anticonvulsants - therapeutic use Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Epilepsy - drug therapy Epilepsy - epidemiology Epilepsy - surgery Epilepsy treatment Evidence-Based Medicine - methods Evidence‐based medicine Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Magnetic resonance imaging Medical sciences Nervous system (semeiology, syndromes) Neurology Neuropharmacology Pharmacology. Drug treatments Randomized Controlled Trial Randomized Controlled Trials as Topic - methods Temporal lobe epilepsy surgery |
| title | Epilepsy surgery, antiepileptic drug trials, and the role of evidence |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A31%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epilepsy%20surgery,%20antiepileptic%20drug%20trials,%20and%20the%20role%20of%20evidence&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Janszky,%20Jozsef&rft.date=2010-06&rft.volume=51&rft.issue=6&rft.spage=1004&rft.epage=1009&rft.pages=1004-1009&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2010.02566.x&rft_dat=%3Cproquest_cross%3E733962594%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733962594&rft_id=info:pmid/20384716&rfr_iscdi=true |